A growing body of cancer research evidence has indicated that activation of gp130/STAT3 induces the expression of multiple survival, proliferation and antiapoptosis associated genes, such as MCL-1, Bcl-2, Bcl-XL, Survivin and cyclin D1. This evidence concerns the gene BCL2L1 and cancer.